Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
↓ Download CSVKey ratios (FY2025)
-519.9%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Operating Income | -$11.92M | -$7.70M | -$5.89M | -$2.34M | -$1.74M | — |
| Net Income | -$11.72M | -$9.14M | -$6.59M | -$5.00M | -$1.15M | — |
| EPS (Diluted) | $-7.16 | $-79.65 | $-3.53 | $-5.04 | $-0.12 | — |
| Total Assets | $10.48M | $2.51M | $5.95M | $8.65M | $651.6K | — |
| Total Liabilities | $8.22M | $1.80M | $1.90M | $975.7K | $2.28M | — |
| Shareholders' Equity | $2.25M | $709.2K | $4.06M | $7.68M | -$1.76M | -$1.69M |
| Cash & Equivalents | $334.0K | $1.92M | $2.58M | $8.42M | $504.7K | — |
| Operating Cash Flow | -$9.48M | -$7.33M | -$5.58M | -$2.67M | -$300.3K | — |
| Capital Expenditures | — | — | $19.0K | — | — | — |
| Shares Outstanding | 2.02M | 163.1K | 2.01M | 1.70M | 9.31M | — |